Elutia Inc., headquartered in the United States, is a pioneering company in the biotechnology industry, specialising in advanced therapeutic solutions. Founded in 2018, Elutia has rapidly established itself as a leader in regenerative medicine, focusing on innovative products that enhance tissue repair and regeneration. With a strong operational presence across North America and Europe, Elutia offers a unique portfolio of biomaterials and cell-based therapies. Their flagship products are distinguished by their cutting-edge technology and commitment to improving patient outcomes. Notably, Elutia has achieved significant milestones, including successful clinical trials that underscore their position in the market. Recognised for their contributions to the field, Elutia Inc. continues to push the boundaries of science, making substantial strides in the development of next-generation therapies that address unmet medical needs.
How does Elutia Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Elutia Inc.'s score of 23 is lower than 73% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Elutia Inc., headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that Elutia Inc. may still be in the early stages of developing its climate commitments or reporting frameworks. As of now, there are no emissions inherited from a parent company or related organisation, indicating that Elutia Inc. operates independently in terms of its environmental impact reporting. Without specific emissions data or reduction initiatives, it is unclear how the company plans to address its carbon footprint or contribute to broader climate goals.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Elutia Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

